news
Researchers have optimised PROTAC substances to degrade and dispose of…
30 March 2020 | By Victoria Rees (Drug Target Review)
Researchers have optimised PROTAC substances to degrade and dispose of proteins that support cancers, by customising their structure and selecting the best ligases.